News
Brief news reports on Tuberculosis
By
RESULTS UK,
ARASA
Published: Nov. 29, 2013, 2:27 p.m.·
Tags:
None
The report details the role that gold mining has in driving the TB epidemic in southern Africa, and calls for a step up in political and corporate will for developing a coordinated international response to the disease.
Read More →
By
Treatment Action Campaign
Published: Nov. 29, 2013, 2:09 p.m.·
Tags:
None
Between September and October 2013, among 91% of the 2,342 public health facilities contacted, a shocking one in five health facilities reported experiencing a stock out or shortage of ARVs and/or TB medicines within the previous three months.
Read More →
By
Global Fund to Fight AIDS, Tuberculosis and Malaria
Published: Nov. 29, 2013, 1:08 p.m.·
Tags:
None
GENEVA – The Global Fund to Fight AIDS, Tuberculosis and Malaria announced new results today that show a substantial increase in the number of people being treated for HIV, in the distribution of insecticide-treated nets to combat malaria and in treatment for TB.
Read More →
By
Michael Carter
Published: Nov. 29, 2013, 12:46 p.m.·
Tags:
None
A low CD4 cell count increases the risk of immune reconstitution inflammatory syndrome (IRIS) for people starting antiretroviral therapy (ART) within two weeks of treatment for tuberculosis (TB), investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The timing of antiretroviral therapy had no impact on the risk of IRIS for people with a CD4 count above 50 cells/mm3.
Read More →
By
Brook Baker
Published: Nov. 29, 2013, 11:18 a.m.·
Tags:
None
Inside US Trade[1] and the USTR[2] have announced that the U.S. is floating new proposals on IP in its marathon Trans-Pacific Partnership Agreement negotiations. Although the U.S. touts its new proposals as being balanced, as prioritizing access to medicines, and as recognizing the interests of developing country negotiating partners, particularly, Peru, Vietnam, Mexico, and Malaysia, its actual proposals offer modest temporary respite at best from only a small fraction of U.S. demands.
Read More →
By
Community Research Advisors Group (CRAG)
Published: Nov. 27, 2013, 11:46 p.m.·
Tags:
None
27 November 2013 - New York - The Community Research Advisors Group (CRAG) is seeking nominations for new members.
Read More →
By
R. Prasad
Published: Nov. 27, 2013, 11:34 p.m.·
Tags:
None
In cases where there is a serious disease like TB meningitis, the index of suspicion for MDR-TB should be very high
Read More →
By
Betsy McKay
Published: Nov. 27, 2013, 11:08 p.m.·
Tags:
None
Process illustrates collision between public health, politics.
Read More →
By
William New
Published: Nov. 27, 2013, 10:56 p.m.·
Tags:
None
Ten global health organisations today launched “Fight the Fakes,” a global campaign against “fake” medicines, aimed at raising awareness about medicines – brand or generic – that are not what they claim to be. Meanwhile, a Swiss pharmaceutical company official was named head of investigations at a top international public health organisation.
Read More →
By
Koketso Moeti and GroundUp staff
Published: Nov. 27, 2013, 10:36 p.m.·
Tags:
None
One of the more promising TB drugs to emerge recently is extremely expensive. The drug is called linezolid and it is patented by Pfizer. One pill costs R676 per day.
Read More →
Page 681 of 878 · Total posts: 10
←First
680
681
682
Last→